Monthly archive | PharmaTutor

Read more about Janssen receives CHMP positive opinion for TREVICTA® recommending approval in EU

Janssen-Cilag International NV announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a Positive Opinion recommending marketing authorisation in the European Union for the medicinal product TREVICTA® (paliperidone palmitate a 3 monthly injection) for the maintenance treatment of schizophrenia. If approved, this 3 monthly injection will allow patients to maintain an optimal level of treatment in their blood with fewer administrations, compared to currently available antipsychotic treatments, and therefore may improve outcomes for patients, carers and HCPs.1 A 1 monthly formulation of paliperidone palmitate (XEPLION®) is approved for the maintenance treatment of schizophrenia in Europe.

Read more about AstraZeneca brilinta preferred over clopidogrel in updated ACC & AHA guideline in acute coronary syndrome

AstraZeneca confirmed that the American College of Cardiology (ACC) and American Heart Association (AHA) have released a treatment guideline on the duration of dual antiplatelet therapy (DAPT). Brilinta (ticagrelor) is now preferred over clopidogrel for the management of patients with acute coronary syndrome (ACS) who have received a coronary stent and in non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) patients treated with medical therapy alone (Class IIa LoE: B-R). This update is the first time the ACC/AHA has recommended Brilinta over clopidogrel for patients who have experienced an ST-elevation myocardial infarction (STEMI).

Read more about Daiichi Sankyo announces phase 3 clinical trial results for AMG 162 (denosumab)

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo), announced that Phase 3 clinical trials for AMG 162 (hereafter, denosumab), a gene recombinant drug for patients with rheumatoid arthritis, has achieved a major objective.

Read more about Janssen announces discontinuation of fulranumab phase 3 development program in Osteoarthritis Pain

Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced that it is discontinuing the Phase 3 development program for fulranumab in osteoarthritis pain. This decision was based on strategic portfolio prioritization and was not based on any emerging safety concerns from the Phase 3 clinical studies with fulranumab.

Read more about Oculus innovative sciences and lipogrid of sweden announce strategic collaboration

Oculus Innovative Sciences, Inc. announced it has finalized a strategic collaborative agreement with the Lipogrid Company of Sweden to develop multiple topical drug delivery formulations based upon the company's Lipogrid® Technology.

3 April 2016

Work as Manager Pharmacovigilance in APCER

APCER Life Sciences is committed to improving health in partnership with its clients. We bring together safety, medical, regulatory, and technology resources to ensure that patients receive the safest, most effective therapies possible. Our global infrastructure of scientific and medical experts, supported by integrated processes and regulatory-compliant technology systems, has proven to be responsive and scalable through exponential growth since our founding in 2007. We are global. It’s more than just a word at APCER Life Sciences. Global operations and relationships are the foundation of our business. We are experts APCER has deep industry knowledge and hands-on experience. Our clients value our safety, medical, regulatory, and technology expertise. We find solutions APCER takes ownership of the challenges you face. No matter how impossible a project may seem, we find solutions and meet your deadlines.

Post: Manager Pharmacovigilance

3 April 2016

Recruitment for Product Manager - Dermatology in Alkem Laboratories

Established in 1973 and headquartered in Mumbai, India, Alkem began operations as a health care marketing company. Alkem has since grown to become India’s seventh largest pharmaceutical company with sales revenues exceeding USD 500 million with a CAGR of 16% over the last five years.
Alkem, one of the India’s leading generic and specialty pharmaceutical companies, is a significant player in the branded drugs and generic drugs space. With a wide ranging presence across acute and chronic therapeutic segments with substantial brand share in the Central Nervous System, Gastro-intestinal, Anti-diabetic, Anti-osteoporosis, Anti-malarial, Cardiovascular, Immunosuppressants, and Nutraceutical segments, Alkem leads the Indian market in the Anti-infective and Pain Management segments.

Post: Product Manager - Dermatology

3 April 2016

Application are invited for Pharmacist in Kidwai Memorial Institute of Oncology

Applications are invited from eligible candidates for the following Group-C Posts in the prescribed format to Peripheral Cancer Centre, Kalburgi (Kidwai Memorial Institute of Oncology - Sub Centre).

Post: Pharmacist

3 April 2016

Vacancy for Research Officer (Non - Medical) in Department of Microbiology, Lady Hardinge Medical College

Following posts are to be filled up onpurely temporary basis in the ICMR Ad - Hoc Extramural Research Project entitled “Characterization and antifungal resistance profile of Candidiasis” in Department of Microbiology, Lady Hardinge Medical College, New Delhi - 110001

Post: Research Officer (Non - Medical)

3 April 2016

Job as Key Account Manager in Procter & Gamble

Procter & Gamble is the innovation leader in our industry. Virtually all the organic sales growth we’ve delivered in the past nine years has come from new brands and new or improved product innovation. We continually strengthen our innovation capability and pipeline by investing two times more, on average, than our major competitors.
P&G. We interact with more than five million consumers each year in nearly 60 countries around the world. We conduct over 15,000 research studies every year. We invest more than $350 million a year in consumer understanding. This results in insights that tell us where the innovation opportunities are and how to serve and communicate with consumers.

Post: Key Account Manager - India

Search

April 2016

RECOMMENDED POSTS

Subscribe with us

Jobs by Category